Sign In
Buy GNOM
$49.01
+0.96 (+1.99%)
At Close: Jun 03, 2026
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Position Increased by IFP Advisors Inc
11:08am, Saturday, 27'th Nov 2021 Dakota Financial News
IFP Advisors Inc increased its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) by 269.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,511 shares of the companys stock after acquiring an additional 2,561 shares []
Equity Market Cap For Technologically Enabled Innovation Likely To Grow Exponentially
10:24am, Wednesday, 24'th Nov 2021
Investment strategies geared to the future evaluate complex dynamics that can evolve rapidly. As innovation's market share has grown, investment capacity - as measured by average days to trade - also
Creative Financial Designs Inc. ADV Takes $389,000 Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)
02:56pm, Friday, 19'th Nov 2021 Dakota Financial News
Creative Financial Designs Inc. ADV bought a new stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) during the third quarter, Holdings Channel.com reports. The fund bought 17,573 shares of the companys stock, valued at approximately $389,000. Several other large investors have also bought and sold shares of the company. Royal Bank of []
ETF Battles: ARKG Vs IDNA Vs GNOM
04:55am, Tuesday, 26'th Oct 2021
Join us for a triple-header to determine the best genomics biotech ETF!
Global X Genomics & Biotechnology ETF: Targeted Fund Provides Strong Growth And Steady Dividend
02:25pm, Monday, 27'th Sep 2021
Global X Genomics & Biotechnology ETF is a passive ETF with a healthcare sector focus.
Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan
02:03pm, Tuesday, 07'th Sep 2021
The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.
How Are Genomics ETFs Responding to Q2 Earnings?
10:00am, Saturday, 14'th Aug 2021
Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.
Snag Next-Generation Tech Exposure with This Genomics ETF
11:35am, Friday, 16'th Jul 2021
ETF investors looking to get in on the next generation of medical technology may want to give the Global X Genomics & Biotechnology ETF (GNOM) a closer look. Genomic sequencing is already playing a p
A Comprehensive Guide to Genomic ETFs
05:17pm, Friday, 09'th Jul 2021
Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.
Genomics ETFs Surge on a Major Breakthrough in CRISPR Study
02:04pm, Wednesday, 30'th Jun 2021
The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.
4 ETF Areas Surged Last Week
01:32pm, Monday, 14'th Jun 2021
These four ETF areas were winners last week.
Top-Performing Biotech ETFs of Last Week
12:02pm, Monday, 14'th Jun 2021
Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.
ETF Battles: ARKG Vs GNOM
02:12pm, Monday, 07'th Jun 2021
Which biotech/genomics ETF is the better play?
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
